醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
MNPR · Monopar Therapeutics
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Monopar Therapeutics（MNPR）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $4.0M；高管董事有效買入 —、有效賣出 —。最近申報 2026-10-05。
買入 Bought—
賣出 Sold$4.0M
有效買入 Effective bought—
有效賣出 Effective sold—
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-10-01 | STARR CHRISTOPHER M Director | 賣出 Sell | 8,400 | $78.50 | $659K | SEC |
| 2026-09-24 | Robinson Chandler Chief Executive Officer, Director | 賣出 Sell | 29,056 | $88.00 | $2.6M | SEC |
| 2026-08-25 | Anderson Raymond Director | 賣出 Sell | 3,142 | $111.77 | $351K | SEC |
| 2026-08-26 | Tsuchimoto Kim R Director | 賣出 Sell | 4,090 | $111.39 | $456K | SEC |
| 2026-08-26 | RIOUX PATRICE Other | 賣出 Sell | 1 | $111.00 | $111 | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-10-01 | STARR CHRISTOPHER M Director | 16,800 | $1.3M | 10b5-1 |
| 2026-09-24 | Robinson Chandler Director, Officer | 29,056 | $2.6M | 10b5-1 |
| 2026-08-26 | Tsuchimoto Kim R Director | 8,180 | $907K | 10b5-1 |
| 2026-08-26 | RIOUX PATRICE Acting Chief Medical Officer | 1 | $111 | 10b5-1 |
| 2026-08-25 | Anderson Raymond Director | 6,284 | $700K | 10b5-1 |
| 2026-07-07 | KLAUSNER ARTHUR J Employer | 5,000 | $485K |
內部人 Insiders
STARR CHRISTOPHER M、Robinson Chandler、Anderson Raymond、Tsuchimoto Kim R、RIOUX PATRICE